Jump to ContentJump to Main Navigation
Show Summary Details

Heterocyclic Communications

Editor-in-Chief: Strekowski, Lucjan

Ed. by Baumstark, Alfons L. / Murata, Shizuaki / Saczewski, Jaroslaw / Stephens, Chad

IMPACT FACTOR increased in 2015: 0.828

SCImago Journal Rank (SJR) 2015: 0.211
Source Normalized Impact per Paper (SNIP) 2015: 0.506
Impact per Publication (IPP) 2015: 0.728

    99,00 € / $149.00 / £75.00*

    See all formats and pricing

    Select Volume and Issue



    Your benefits:
    • Significant developments in heterocyclic chemistry
    • Synthetic routes to heterocyclic compounds with high biological activity
    • Imperative topics including theoretical analysis
    • Cutting-edge trends
    • Easy traceability through detailed experimental descriptions

    Aims and Scope

    Heterocyclic Communications (HC) is a bimonthly, peer-reviewed journal publishing preliminary communications, research articles, and reviews on significant developments in all phases of heterocyclic chemistry, including general synthesis, natural products, computational analysis, considerable biological activity and inorganic ring systems. Clear presentation of experimental and computational data is strongly emphasized. Heterocyclic chemistry is a rapidly growing field. By some estimates original research papers in heterocyclic chemistry have increased to more than 60% of the current organic chemistry literature published. This explosive growth is even greater when considering heterocyclic research published in materials science, physical, biophysical, analytical, bioorganic, pharmaceutical, medicinal and natural products journals. There is a need, therefore, for a journal dedicated explicitly to heterocyclic chemistry and the properties of heterocyclic compounds.

    • Development of novel synthetic methods
    • Significant improvement of known synthetic methods
    • Chemistry of natural products
    • Superior biological activity of novel heterocyclic compounds, rational design and synthesis of new drug candidates targeting specific biological receptors
    • Application of heterocyclic compounds as probes for biomolecules in biophysical and bioanalytical chemistry
    • Development of new substrates and catalysts in materials chemistry

    Article formats
    Preliminary Communications, Original Research Articles, Review Articles

    > Information on submission process


    Type of Publication:
    researchers in the field of heterocyclic, bioorganic, bioinorganic and medicinal chemistry

    Submission of Manuscripts

    Instructions for Authors

    You can easily submit your manuscript online. Simply go to http://mc.manuscriptcentral.com/hetcyclcom and you will be guided through the whole peer-reviewing and publishing process.

    Your benefits of publishing with us Submission process
    • Before preparing a manuscript please have a look at our Instructions for Authors
    • Submission of your paper via our submission management tool
    • Reviewers: Authors must provide the names and e-mail addresses of at least 3 potential reviewers. Authors may also indicate names of reviewers whom they wish to be excluded from reviewing their manuscripts
    • Peer review process (you will be guided through every step)
    • Fast decision on your paper (2-3 weeks from submission to first decision, including acceptances without revision)
    • When manuscripts are accepted subject to revision, the revised manuscript should be returned within 2 months
    • If accepted: authors have the option to publish it open access
    Please note
    • Manuscripts must be written in clear and concise English
    • Before submitting your article please have a look at our Publication Ethics Statement and our copyright agreement
    • Once your article is accepted you have the option to publish it open access
    • Our repository policy allows you to distribute 30 PDF copies of your published article to colleagues (the PDF has to include the information that it is an author's copy). Please also feel free to distribute the link to the online abstract.
    • If you have any general questions please visit our FAQ page for authors

    We look forward to receiving your manuscript!

    More ...


    Heterocyclic Communication was previously published by Freund Publishing House Ltd.

    Other publications in the field

    Abstracting & Indexing

    Heterocyclic Communications is covered by the following services:

    • Baidu Scholar
    • Cabell's Directory
    • Celdes
    • Chemical Abstracts Service (CAS) - CAplus
    • Chemical Abstracts Service (CAS) - SciFinder
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Elsevier - Reaxys
    • Elsevier - SCOPUS
    • Genamics JournalSeek
    • Google Scholar
    • J-Gate
    • JournalTOCs
    • Naviga (Softweco)
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • ReadCube
    • ResearchGate
    • SCImago (SJR)
    • Sherpa/RoMEO
    • Summon (Serials Solutions/ProQuest)
    • TDOne (TDNet)
    • Thomson Reuters - Current Contents/Physical, Chemical and Earth Sciences
    • Thomson Reuters - Journal Citation Reports/Science Edition
    • Thomson Reuters - Science Citation Index Expanded
    • Ulrich's Periodicals Directory/ulrichsweb
    • WorldCat (OCLC)

    Editorial Information

    Lucjan Strekowski, Georgia State University, Atlanta, USA (lucjan@gsu.edu)

    Associate Editors
    A. Baumstark, Georgia State University, Atlanta, USA (abaumstark@gsu.edu)
    Shizuaki Murata, Nagoya University, Nagoya, Japan (murata@urban.env.nagoya-u.ac.jp)
    Jaroslaw Saczewski, Medical University of Gdansk, Gdansk, Poland (js@gumed.edu.pl)
    Chad E. Stephens, Augusta University, Augusta, USA (cstephe7@augusta.edu)

    Editorial Board
    S. Abu-Orabi, Association of Arab Universities, Amman, Jordan (abuorabi@excite.com)
    S. Achilefu, Washington University, St. Louis, USA (achilefus@mir.wustl.edu)
    E.B. Arevalo-Garcia, Educational Research Institute, Warsaw, Poland (ebarevalog@gmail.com)
    M. Brimble, University of Auckland, Auckland, New Zealand (m.brimble@auckland.ac.nz)
    R.A. Bunce, Oklahoma State University, Stillwater, USA (rab@okstate.edu)
    M. Elliott, University of Cardiff, Cardiff, UK (elliottmc@cardiff.ac.uk)
    D.C. Gautam, University of Rajasthan, Jaipur, India (drdcgautam@yahoo.co.in)
    M.W. Germann, Georgia State University, Atlanta, USA (mwg@gsu.edu)
    D. Hamelberg, Georgia State University, Atlanta, USA (dhamelberg@gsu.edu)
    M.M. Henary, Georgia State University, Atlanta, USA (mhenary1@gsu.edu)
    H. Kiyota, Okayama University, Okayama, Japan (kiyota@okayama-u.ac.jp)
    K. Kiec-Kononowicz, Jagiellonian University, Kraków, Poland (mfkonono@cyf-kr.edu.pl)
    M. Kumar, University of Rajasthan, Jaipur, India (mahendrakpathak@gmail.com)
    H. Nishino, Kumamoto University, Kumamoto, Japan (nishino@sci.kumamoto-u.ac.jp)
    T. Okano, Jikei University, Tokyo, Japan (okano@jikei.ac.jp)
    S.S. Panda, Augusta University, Augusta, USA (sipanda@augusta.edu)
    S.E. Patterson, UMN Center for Drug Design, Minneapolis, USA (patte219@umn.edu)
    J. Reddy, Dr. Jagath Reddy's Heterocyclics, Hyderabad, India (jagathreddy@heterocyclics.com)
    S. Routier, University of Orléans, Orléans, France (sylvain.routier@univ-orleans.fr)
    A. Rykowski, University of Podlasie, Siedlce, Poland (rykowski@ap.siedlce.pl)
    F. Saczewski, Medical University of Gdansk, Gdansk, Poland (saczew@amg.gda.pl)
    S.W. Schneller, University of Auburn, Auburn, USA (schnest@auburn.edu)
    B.C.G. Söderberg, University of West Virginia, Morgantown, USA (bjorn.soderberg@mail.wvu.edu)
    V. Traven, Russian University of Chemical Technology, Moscow, Russia (traven@muctr.edu.ru)
    K. Weisz, Ernst Moritz Arndt University, Greifswald, Germany (weisz@uni-greifswald.de)
    P.-F. Xu, Lanzhou University, Lanzhou, China (xupf@lzu.edu.cn)
    P. Zajdel, Jagiellonian University Medical College, Kraków, Poland (pawel.zajdel@uj.edu.pl)
    N. Zaware, Mount Sinai School of Medicine, New York, USA (nzaware@gmail.com)
    A. Zawisza, University of Łódź, Łódź, Poland (aniazawisza@poczta.onet.pl)

    Comments (3)

    Please log in or register to comment.
    • I would really appreciate if you can update me about the publishing charges of Research Article in Heterocyclic Communications

      posted by: Rayees Mohammed on 2012-06-27 09:16 AM (Europe/Berlin)

    • Thanks for your interest! There are no publishing charges for this journal.

      posted by: De Gruyter Online on 2012-06-29 02:40 PM (Europe/Berlin)

    • Aswan Univesity, Aswan, Egypt

      posted by: Hussain Soleiman on 2016-05-03 10:33 AM (Europe/Berlin)